131 results
Page 3 of 7
6-K
EX-99.1
w84an cdmn
3 Sep 14
Live Filing
12:00am
6-K
sgwhira7f g32
18 Jun 14
Current report (foreign)
12:00am
6-K
EX-99.1
81c1sn l4l
24 Jan 14
Live Filing
12:00am
6-K
47iqm 1f2mo494dn
17 Jan 14
Current report (foreign)
12:00am
6-K
EX-99.1
7n8je131j5x60 f5wd7c
4 Oct 13
Live Filing
12:00am
6-K
EX-99.1
glt01c6h2r2mogx
1 Oct 13
Live Filing
12:00am
6-K
EX-99.1
209jjleyed5 sl44
26 Sep 13
Live Filing
12:00am
6-K
EX-99.1
956kvh 1wca6x
1 Jul 13
Live Filing
12:00am
6-K
EX-32.1
ytevwe8dhqr5c2u1z11g
12 Jun 13
Live Filing
12:00am
6-K
EX-99.1
9cup9 iy55
21 Mar 13
Live Filing
12:00am
6-K
towpj9a8zg1wpmgel cy
21 Mar 13
Live Filing
12:00am
6-K
EX-99.1
xvoy61
14 Mar 13
Teva to Present New Research on CNS Product Portfolio and Pipeline at 2013 American Academy of Neurology Annual Meeting
12:00am
6-K
EX-99.1
s95ui1 v8r8jnqfh
6 Mar 13
Live Filing
12:00am
6-K
EX-99.1
h5i7wnwabxu8yora8
5 Feb 13
Teva Announces First Patient Enrolled In Largest Clinical Study to Date Evaluating Azilect® for Mild Cognitive Impairment In Parkinson’s Disease
12:00am
6-K
EX-99.1
q92x83a2wjaz091n
10 Oct 12
New Data Presented at the 28TH Ectrims Congress Showcase Teva’s Ongoing Commitment to Multiple Sclerosis Research
12:00am
6-K
EX-99.1
8bykk 4qzhcb5wlk
8 Aug 12
Teva to Initiate Third Phase Iii Trial of Oral Laquinimod for the Treatment of Relapsing Remitting Multiple Sclerosis
12:00am
6-K
ydjdg
8 Aug 12
Current report (foreign)
12:00am
6-K
EX-99.1
o6ozollmfx
18 Apr 12
Teva Announces New Data on Central Nervous System Products to Be Presented at 2012 American Academy of Neurology Annual Meeting
12:00am